Combining idebenone and rosuvastatin prevents atherosclerosis by suppressing oxidative stress and NLRP3 inflammasome activation.

导出 LinkOut

翻译打印收藏纠错

作者： Wenfei,Yu ^[1] ; Wei,Jiang ^[2] ; Wenjing,Wu ^[3] ; Guangyu,Wang ^[3] ; Dandan,Zhao ^[3] ; Chuanzhu,Yan ^[4] ; Pengfei,Lin ^[5]

作者单位： Department of Neurology, Qilu Hospital of Shandong University, Jinan, 250012, Shandong Province, China; University of Health and Rehabilitation Sciences, No. 17, Shandong Road, Shinan District, Qingdao City, Shandong Province, China. ^[1] Department of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University, No. 600 Tianhe Road, Guangzhou, 510630, Guangdong Province, China. ^[2] Department of Neurology, Qilu Hospital of Shandong University, Jinan, 250012, Shandong Province, China. ^[3] Department of Neurology, Qilu Hospital of Shandong University, Jinan, 250012, Shandong Province, China. Electronic address: czyan@sdu.edu.cn. ^[4] Department of Neurology, Qilu Hospital of Shandong University, Jinan, 250012, Shandong Province, China. Electronic address: lpfsdu@foxmail.com. ^[5]

关键词 Atherosclerosis Idebenone NLRP3 inflammasome Oxidative stress

DOI 10.1016/j.ejphar.2023.175911

PMID 37451421

发布时间 2023-08-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

European journal of pharmacology

2023年955卷

175911页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Combining idebenone and rosuvastatin prevents atherosclerosis by suppressing oxidative stress and NLRP3 inflammasome activation.

European journal of pharmacology

相似文献

European journal of pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Combining idebenone and rosuvastatin prevents atherosclerosis by suppressing oxidative stress and NLRP3 inflammasome activation.

European journal of pharmacology

相似文献

European journal of pharmacology

相关期刊

检索历史清除